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We report a case of rickettsialpox from North Carolina con-
firmed by serologic testing. To our knowledge, this case is the
first to be reported from this region of the United States. Includ-
ing rickettsialpox in the evaluation of patients with eschars or
vesicular rashes is likely to extend the recognized geographic
distribution of Rickettsia akari, the etiologic agent of this
disease.
ickettsialpox is caused by infection with Rickettsia akari.
Disease in humans was first described in 1946 in resi-
dents of apartments clustered in a three-block area in the bor-
ough of Queens, New York City (1). Subsequently, small
outbreaks of rickettsialpox were recognized in several U.S. cit-
ies, including Boston, Cleveland, Philadelphia, Pittsburgh, and
West Hartford (2). Most cases to date have occurred in large
metropolitan areas of the northeastern United States; about
half the described cases have occurred in New York City.
However, rickettsialpox is likely more common in the United
States than suggested by the relatively small number of
reported cases during the past 50 years (3,4).
R. akari is transmitted among house mice (Mus musculus)
and to humans by the house mouse mite (Liponyssoides san-
guineus) (2). Recently, cases of rickettsialpox have been
reported in residents of the Ukraine (5) and Croatia (6). Isola-
tions have also been made from Korean voles in an area where
rickettsialpox has not been reported (7). These data suggest
that silent sylvan cycles of R. akari infection exist and that the
organism is more widely distributed than currently appreci-
ated. To our knowledge, rickettsialpox has not previously been
reported in patients in the southern United States. We describe
a recently diagnosed R. akari infection in a man who resides in
a suburban area of North Carolina. 
Case Report
A 48-year-old man who worked at a golf course was
admitted to a North Carolina hospital with fevers, chills, head-
aches, and a rash. Seven days before admission, he noted dis-
comfort on the back of his right calf. The patient stated that he
thought something had bitten him at this site, although he had
not seen any insects or ticks. Over the next 2 days, thigh ten-
derness and a papule developed at the site of the original dis-
comfort. Three days before admission, the papule began to
ulcerate, and fevers, chills, headaches, and general malaise
were present. Two days before admission, several red macules
appeared over the anterior chest. Over the next 24 hours, vesi-
cles appeared near the center of these macules.
The patient had a pet dog and cat and had not traveled out-
side North Carolina in the 3 months before admission. He
reported that he had no known exposures to ticks or recent tick
bites. He was unaware of any rodents in his house or any local
rodent extermination projects. However, he recalled that a
stray cat periodically brought dead mice to the general area
where he worked, although he never directly touched them. 
On admission, the patient appeared ill and was febrile. An
eschar was present on his posterior right lower leg (Figure 1).
Approximately 30 erythematous macules were noted on his
trunk, arms, and legs (Figures 2 and 3). Many of these macules
had small central vesicles. Laboratory testing showed normal
values for electrolytes and creatinine, hematocrit, and leuko-
cytes. His platelet count was 85,000/mm3. Routine blood cul-
tures were sterile.
A diagnosis of rickettsialpox was made, and therapy was
started with doxycycline and cefazolin. After 48 hours, the
patient became afebrile, and his constitutional symptoms
abated. He was discharged, took doxycycline orally for an
additional 7 days, and recovered completely.
Two serum samples were submitted to the Centers for Dis-
ease Control and Prevention for confirmatory testing. Samples
were tested by a standard immunofluorescent antibody assay
(IFA) for immunoglobulin G antibodies reactive with R. akari
and R. rickettsii antigens. Because of cross-reactivity among
the spotted fever group rickettsiae, confirmatory cross-adsorp-
tion testing was done as described (8). Higher reciprocal titers
were obtained to R. akari antigens than to R. rickettsii antigens
in both samples (reciprocal titers of 1,024 versus 512 on
August 29 and 512 versus 256 on October 11, respectively).
Adsorption with R. akari greatly reduced titers to both antigens
(<16 to both antigens for both samples), whereas adsorption
with R. rickettsii only partially lowered titers to both antigens
(512 versus 256 for the first sample; 128 versus 64 for the
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Figure 1. Eschar on posterior right calf of patient with rickettsialpox.DISPATCHES
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second sample). This pattern of differential reduction in titers is
confirmatory for a serologic diagnosis of rickettsialpox (9).
Conclusions
This patient’s illness was typical of rickettsialpox. He had
a classic eschar, and his vesicular rash, severe headache, and
thrombocytopenia are characteristic findings of infection with
R. akari. However, not all patients with rickettsialpox have a
vesicular rash. Although isolation of R.  akari was not
attempted and a skin biopsy was not performed, the results of
the IFA testing confirmed the diagnosis.
Rickettsialpox may have occurred sporadically in North
Carolina in the past, but the incidence of this disease in this
state is probably extremely low. As Figures 1–3  illustrate,
infection with R.  akari produces unusual and characteristic
skin abnormalities. Because cases of rickettsialpox may be
confused with chickenpox or other viral exanthematous dis-
eases, misdiagnosis may occur when sporadic cases occur in
areas where the disease is unknown to local practitioners. The
vesicular rash of rickettsialpox may be easily confused with
the skin rash seen in patients with chickenpox; however, the
presence of one or more eschars at the site(s) of inoculation,
the lack of successive crops of vesicles over time, and the
presence of thrombocytopenia should lead clinicians to
exclude varicella-zoster virus (formal name: Human herpesvi-
rus 3) as the etiologic agent.
In large cities, R. akari is maintained in a cycle that
includes the house mouse and its associated mite (2). Although
our patient did not recall direct exposure to rodents, he did
recall a stray cat’s bringing mice into the work area. The
patient may have been exposed to infected mites in this man-
ner, although he may also have been unknowingly exposed to
rodents and their mites at some other location. 
Evaluation of patients with eschars or vesicular rashes for
rickettsialpox is likely to extend the recognized geographic
distribution of Rickettsia akari, the etiologic agent of this
disease.
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Figure 2. Multiple papulovesicles involving the upper trunk on a patient
with rickettsialpox.
Figure 3. Closer view of papulovesicular lesions on patient with rickett-
sialpox.